Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

Clinical trial NCT00967681 · COMPLETED

Trial details

NCT number: NCT00967681
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Fibrocystic Disease

Start date: 2009-09-01
Primary completion: 2011-04-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.